Insurance claims data compared 33k RA to 1079 PM/DM pts and showed overall lower use of statin R in PM/DM (27% vs 181%, p<0.0001). But if DM/PM-HLD pts used statins they had lower mortality rate than non-users (HR = 0.515, p = 0.0273) https://t.co/El0mmNZ8ZR https://t.co/428YmGlV5k
Links:
Low utilization of statins in patients with dermatomyositis/polymyositis and hy…
https://bit.ly/41T8Kwk
11-01-2024